Among individuals who adhered to the treatment regimen, weight loss reached up to 19.9%
The most common adverse events among participants treated with retatrutide (4 mg, 9 mg, 12 mg, vs
Cholinergic modulation of CRH and non-CRH neurons in Barringtons nucleus of the mouse
Others have had some luck with antacids and fiber supplements
The net result is a measurable shift in appetites and diet patterns resulting in less processed food, and greater consumption of nutritionally dense, unprocessed items (Dilley et al., 2025)
The GLP-1 medications for diabetes include: Dulaglutide (Trulicity) Exenatide (Bydureon, Byetta) Liraglutide (Victoza) Lixisenatide (Adlyxin) Semaglutide (Ozempic, Rybelsus) Tirzepatide (Mounjaro) People taking GLP-1s for diabetes had significant weight loss and improvements in cardiovascular factors